$HHSE-NEWS:..With.the.movie.TORN, Hemdale-is

New Post Public Reply Private Reply Replies (0) Message Board
HHSErocks Steel Reserve #9148
131
$HHSE-NEWS:..With.the.movie.TORN, Hemdale-is Back.

https://deadline.com/2025/07/hemdale-back-tor...236456985/

Mike Fleming Jr: Hemdale Back From Dead With Provocative ‘Torn’;

By Mike Fleming Jr

Mike Fleming Jr
Co-Editor-in-Chief, Film

@DeadlineMike
More Stories By Mike
Mike Fleming Jr: Hemdale Back From Dead With Provocative ‘Torn’; Donald Trump’s Beak-Wetting Right Out Of ‘The Godfather Part II’
Richard Gladstein Tapped Executive Director Of Hamptons Film Festival
Langley Perer Loses Cancer Battle; Manager And Producer Was 44
View All

July 14, 2025 1:13pm
2
Comments
Services to share this page.
Share on Facebook
Post
Share to Flipboard
Email
Show more sharing options
Donald Trump and Gastone Moschin as Don Fanucci in a scene from the movie The Godfather Part II
Donald Trump and Gastone Moschin as Don Fanucci in 'The Godfather Part II'
Getty/Paramount

EXCLUSIVE: Hemdale Films, the one film production company to generate back-to-back Best Picture Oscar winners (Platoon and The Last Emperor) , is re-emerging for the first time in forever . Revived by Eric Parkinson as a releasing label, Hemdale will release Torn: The Israeli-Palestine Poster War on NYC Streets .

The provocative documentary by director Nim Shapira focuses on the street war that broke out between pro-Israel and pro-Palestinian groups that tore down each other’s messages about the 250 hostages taken by Hamas during the October 7 terror attack in Israel. The posters inflamed heated passion among those who put them up to raise awareness of the hostages and those who tore them down to show their opposition to Israel’s subsequent Gaza offensive. It led to heated arguments and often violence.

Hemdale will open the film in theaters September 5 in New York and Los Angeles with a rollout to follow in the fall and a digital release later on.

Related Stories
Donald Trump and the logo for CBS' 60 Minutes
What’s Next In The Trump-CBS, Paramount-Skydance Saga

Trump Celebrity Supporters: Famous Folks In Favor Of The 47th President
Shapira focused on 10 deeply personal stories for a film that unravels the ideological conflict and explores the limits of empathy in today’s fractured public discourse. Pic has so far had over 50 pre-release screenings across the U.S. and Canada, igniting discourse in major cities including New York, Boston, Chicago, Toronto and San Francisco.

Watch on Deadline
01:45

33:57





So how did Hemdale, the once highflying independent company started by John Daly and actor David Hemmings — best known for playing a Roman senator in Ridley Scott’s Gladiator — emerge from film history to be back in the game 30 years after becoming defunct?

First brought in to the label at the behest of owner Credit Lyonnais in 1991, Parkinson kept a candle in the window all these years for Hemdale, after the company became functionally idle following the sale of its Oscar-winning film library to MGM in 1996. Parkinson said he walked away with the Hemdale name rights, then waited for the right film to relaunch the brand as a releasing division under Hannover House, the 32-year-old independent media company .

Hemdale was started by Daly, who sold insurance, and Hemmings way back in 1967. They first managed rock bands like Black Sabbath, which coincidentally just played its final concert for the Ozzy Osbourne-fronted metal band. Hemdale financed live productions like Grease, and promoted boxing matches like the Muhammad Ali-George Foreman clash “Rumble in the Jungle.” But the true passion for Daly and Hemmings was film, and they had an enviable run.

For a while. The hits ranged from The Terminator to Hoosiers, Salvador, River’s Edge, At Close Range, Platoon, The Last Emperor and Return of the Living Dead. As is often the case with taste-making indies, money was always a problem.

I recall James Cameron once telling me that he had to find the money to end his seminal film with Linda Hamilton’s Sarah Connor and her “You’re terminated, f*cker” factory scene. Daly told Cameron he didn’t have the money for that, and to end the picture earlier, when Michael Biehn’s Kyle Reese places the explosive in the gasoline tanker driven by the cyborg played by Arnold Schwarzenegger. You wonder if that franchise would have become all that it did, had they cheap-ed out on the ending. Cameron, who earlier sold his rights to producer Gale Anne Hurd for $1 with the caveat he could not be replaced as director, would not be denied.

That predated Parkinson, who arrived on the scene in 1991 as a crisis manager planted by the French bank Credit Lyonnais to protect its investment in Hemdale and other Hollywood holdings.

“My title was President of the ‘to be formed Home Video Division,’” he recalled. “And the video division did great. We generated a lot of money. We were able to pay down the debt from $110 million to $58 million, and I attribute a lot of that to Terminator and tying in the re-release of Terminator with Terminator 2. After a period of time, Credit Lyonnais lost interest in the movie business because of the amount of money it invested, mostly in Giancarlo Parretti, and MGM. They took a lot of the companies, Orion, Dino De Laurentiis, Embassy Pictures, Hemdale, Cannon Pictures, all those companies that had loans. They rolled them all into MGM to try to make that business work. After five years there was a forced unwinding of Hemdale, and that hit John and David harder than anybody else. It had been their whole lives. I was still a young guy in my late 30s, and I made the deal that at some point in time, if I had meritorious pictures, then I would relaunch the label. The brand name was the only thing that wasn’t sold with the assets.”

He reincorporated Hemdale, and waited for the right acquisition to come along. He sparked to Torn.

“It had to be something I felt would honor the memory of John’s commitment to quality. And that’s not to say that Hannover House releases don’t have quality, but let’s be honest, some low-budget horror films aren’t going to be quite as commercially or critically meritorious as something that potentially has an Oscar nomination.”

Parkinson hopes Hemdale can become active again, not just as a distributor but as a maker of movies. They are percolating Tempus Porta, a film gearing up to shoot in Malta, and they’re attempting to work with Oliver Stone again on A Child’s Night Dream. That’s a novel Stone wrote before he served as an infantryman in Vietnam, getting wounded twice in combat and winning the Bronze Star, Purple Heart and other medals, experiences that informed his Best Picture- and Best Director-winning film Platoon. Stone’s son Sean has been pining to direct it.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Macao's 25-Year Journey: Celebrating Growth and Prosperity

Updated Category News Views 161

Macao's Remarkable Development Over 25 Years In a vibrant celebration of progress, Macao recently marked the significant milestone of its 25th anniversary since its return to the motherland. A special publication by an English-language newspaper highlighted various achievements that the region has made during this transformative period. Economic Growth and Transformation...

Continue Reading
Opportunity to Address Losses: Join Tempus AI Class Action

Updated Category News Views 128

Investors Encouraged to Participate in Tempus AI Class Action The law firm Robbins Geller Rudman & Dowd LLP is actively reaching out to investors of Tempus AI, Inc. (NASDAQ: TEM) who have experienced notable financial losses. They have announced an opportunity for eligible investors to take the lead in an associated class action lawsuit. This potential action stems from...

Continue Reading
Muncy Columbia Financial Corporation's Strong Q4 2024 Earnings

Updated Category News Views 99

Muncy Columbia Financial Corporation's Financial Outlook Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), after releasing its unaudited consolidated financial statements for the fourth quarter of 2024, has demonstrated significant improvement over the previous year. Fourth Quarter 2024 Financial Highlights For the quarter ending December 31, 2024,...

Continue Reading
Caris Life Sciences Expands Cancer Research Alliance

Updated Category News Views 119

Caris Life Sciences Expands Cancer Research Alliance Caris Life Sciences® (NASDAQ: CAI), a forefront player in precision medicine and next-generation AI TechBio, is excited to share the arrival of Providence Swedish Cancer Institute into the esteemed Caris Precision Oncology Alliance (Caris POA). This addition enhances their collective mission to revolutionize cancer...

Continue Reading
Zumiez Inc. Gears Up for First Quarter 2025 Financial Report

Updated Category News Views 263

Upcoming Financial Report for Zumiez Inc. Zumiez Inc. (NASDAQ: ZUMZ) has recently made an exciting announcement regarding its financial performance. The company is set to release its first quarter results for fiscal 2025 on June 5, after the stock market closes. This pivotal moment is eagerly anticipated by investors and stakeholders alike, as it will provide valuable...

Continue Reading